ATOSSA THERAPEUTICS, INC. (ATOS) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K/A
Revenues:
Product sales								0.0
Total revenues [+]	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Products								0.0
Revenue growth							-100.0%	-95.6%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.1
Gross margin								-7431.9%
Selling, general and administrative [+]	12.6	11.3	8.0	10.6	7.2	4.9	6.5	10.3
Sales and marketing								1.4
General and administrative	12.6	11.3	8.0	10.6	7.2	4.9	6.5	8.8
Research and development	15.1	9.2	6.6	6.6	4.2	2.3	0.8	2.4
EBITDA [+]	-27.7	-20.5	-14.6	-17.2	-11.4	-7.1	-6.9	-12.5
EBITDA growth	35.1%	40.8%	-15.4%	51.1%	61.4%	1.6%	-44.4%	33.7%
EBITDA margin								-710238.4%
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3
EBITA	-27.7	-20.5	-14.6	-17.2	-11.4	-7.1	-7.2	-12.8
EBITA margin								-725746.2%
Amortization of intangibles				0.0	0.0	0.1
EBIT [+]	-27.7	-20.5	-14.6	-17.3	-11.4	-7.2	-7.2	-12.8
EBIT growth	34.9%	40.5%	-15.4%	51.0%	59.1%	-0.9%	-43.2%	29.9%
EBIT margin								-725746.2%
Non-recurring items [+]						0.5	0.7
Asset impairment						0.5	0.7
Interest income	0.9	0.0
Interest income	0.9	0.0
Other income (expense), net [+]	-0.1	-0.1	-3.2	0.0	0.0	-0.5	1.6	0.0
Change in fair value of warrants			-2.3			-0.3
Other	-0.1	-0.1	0.1	0.0	0.0	0.0		0.0
Pre-tax income	-27.0	-20.6	-17.8	-17.2	-11.4	-8.1	-6.4	-12.8
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-27.0	-20.6	-22.3	-17.2	-22.9	-10.7	-6.4	-15.8
Net margin								-896491.6%

Basic EPS [+]	($0.21)	($0.18)	($1.97)	($2.03)	($5.50)	($10.97)	($2.16)	($6.73)
Growth	20.8%	-91.1%	-2.7%	-63.1%	-49.8%	407.5%	-67.9%	1229.6%
Diluted EPS [+]	($0.21)	($0.18)	($1.97)	($2.03)	($5.50)	($10.97)	($2.16)	($6.73)
Growth	20.8%	-91.1%	-2.7%	-63.1%	-49.8%	407.5%	-67.9%	1229.6%

Shares outstanding (basic) [+]	126.6	117.0	11.3	8.5	4.2	1.0	2.9	1.9
Growth	8.3%	934.1%	33.1%	104.4%	326.5%	-66.9%	55.5%	-92.1%
Shares outstanding (diluted) [+]	126.6	117.0	11.3	8.5	4.2	1.0	2.9	1.9
Growth	8.3%	934.1%	33.1%	104.4%	326.5%	-66.9%	55.5%	-92.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.